发明申请
US20070037147A1 Endogenous retrovirus polypeptides linked to oncogenic transformation
审中-公开
与致癌转化相关的内源性逆转录病毒多肽
- 专利标题: Endogenous retrovirus polypeptides linked to oncogenic transformation
- 专利标题(中): 与致癌转化相关的内源性逆转录病毒多肽
-
申请号: US10497786申请日: 2002-12-09
-
公开(公告)号: US20070037147A1公开(公告)日: 2007-02-15
- 发明人: Pablo Garcia , Stephen Hardy , Lewis Williams , Jaime Escobedo
- 申请人: Pablo Garcia , Stephen Hardy , Lewis Williams , Jaime Escobedo
- 优先权: WOPCT/US01/47824 20011207
- 国际申请: PCT/US02/39344 WO 20021209
- 主分类号: C12Q1/70
- IPC分类号: C12Q1/70 ; C12Q1/68
摘要:
HERV-K human endogenous retroviruses show up-regulated expression in tumors. In particular, splicing events in the env region generate a series of transcripts which utilise the +2 reading frame, relative to the env reading frame. The proteins show activity typical of transcriptional regulators, and they also have oncogenic potential. Two related proteins, PCAP2 and PCAP3, are strongly associated with breast cancer and prostate cancer, respectively. PCAP4 stimulates cell division. These proteins can be used in cancer diagnosis and therapy, and are also drug target e.g. for adjuvant therapy. The identification of these splice products is remarkable because full sequence information has been available for HERV-K viruses since 1986.
信息查询